期刊文献+
共找到224篇文章
< 1 2 12 >
每页显示 20 50 100
Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer 被引量:2
1
作者 Angeles C Tecalco-Cruz Josué O Ramírez-Jarquín 《World Journal of Clinical Oncology》 CAS 2018年第4期60-70,共11页
Estrogen receptor alpha(ERα) is detected in more than 70% of the cases of breast cancer. Nuclear activity of ERα, a transcriptional regulator, is linked to the development of mammary tumors, whereas the extranuclear... Estrogen receptor alpha(ERα) is detected in more than 70% of the cases of breast cancer. Nuclear activity of ERα, a transcriptional regulator, is linked to the development of mammary tumors, whereas the extranuclear activity of ERα is related to endocrine therapy resistance. ERα polyubiquitination is induced by the estradiol hormone, and also by selective estrogen receptor degraders, resulting in ERα degradation via the ubiquitin proteasome system. Moreover, polyubiquitination is related to the ERα transcription cycle, and some E3-ubiquitin ligases also function as coactivators for ERα. Several studies have demonstrated that ERα polyubiquitination is inhibited by multiple mechanisms that include posttranslational modifica-tions, intera-ctions with coregula-tors, a-nd forma-tion of specific protein complexes with ERα. These events are responsible for an increase in ERα protein levels and deregulation of its signaling in breast cancers. Thus, ERα polyubiquitination inhibition may be a key factor in the progression of breast cancer and resistance to endocrine therapy. 展开更多
关键词 estrogen receptor alpha POLYUBIQUITINATION BREAST cancer estrogen receptor alpha
下载PDF
Estrogen receptor alpha gene amplification in breast cancer:25 years of debate 被引量:2
2
作者 Frederik Holst 《World Journal of Clinical Oncology》 CAS 2016年第2期160-173,共14页
Twenty-five years ago,Nembrot and colleagues reported amplification of the estrogen receptor alpha gene(ESR1) in breast cancer,initiating a broad and still ongoing scientific debate on the prevalence and clinical sign... Twenty-five years ago,Nembrot and colleagues reported amplification of the estrogen receptor alpha gene(ESR1) in breast cancer,initiating a broad and still ongoing scientific debate on the prevalence and clinical significance of this genetic aberration,which affects one of the most important genes in breast cancer.Since then,a multitude of studies on this topic has been published,covering a wide range of divergent results and arguments.The reported prevalence of this alteration in breast cancer ranges from 0% to 75%,suggesting that ESR1 copy number analysis is hampered by technical and interpreter issues.To date,two major issues related to ESR1 amplification remain to be conclusively addressed:(1) The extent to which abundant amounts of messenger RNA can mimic amplification in standard fluorescence in situ hybridization assays in the analysis of strongly expressed genes like ESR1,and(2) the clinical relevance of ESR1 amplification:Such relevance is strongly disputed,with data showing predictive value for response as well as for resistance of the cancer to anti-estrogen therapies,or for subsequent development of cancers in the case of precursor lesions that display amplification of ESR1.This review provides a comprehensive summary of the various views on ESR1 amplification,and highlights explanations for the contradictions and conflicting data that could inform future ESR1 research. 展开更多
关键词 estrogen receptor alpha GENE BREAST cancer TAMOXIFEN GENE AMPLIFICATION Methodology
下载PDF
T29C genotype polymorphism of estrogen receptor alpha is associated with initial response to interferon-alpha therapy in chronic hepatitis B patients 被引量:4
3
作者 Zhang, Ting-Ting Zhang, Zhen-Hua +3 位作者 Gao, Yu-Feng Zhang, Ya-Fei Yang, Dong-Liang Li, Xu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2010年第3期275-279,共5页
BACKGROUND: Virological clearance, delayed progression to cirrhosis or liver cancer, and increased survival are the long-term goals of antiviral therapy in chronic hepatitis B patients. Identification of host factors ... BACKGROUND: Virological clearance, delayed progression to cirrhosis or liver cancer, and increased survival are the long-term goals of antiviral therapy in chronic hepatitis B patients. Identification of host factors correlated with therapeutic response may contribute greatly to individual treatment. This study aimed at investigating whether T29C genotype polymorphism of estrogen receptor alpha (ESR1) is associated with the initial response to interferon-alpha (IFN-alpha) therapy in chronic hepatitis B patients. METHODS: The initial responses of 100 patients to IFN-alpha therapy were evaluated and compared by classifying them into three groups according to T29C genotype polymorphism of ESR1: T/T, TIC, and C/C genotype groups. Polymerase chain reaction-restriction fragment length polymorphism was used to analyze the genotype polymorphism in T29C. RESULTS: The frequency of initially combined response was markedly higher in both the T/T and TIC groups than in the C/C group (Z=10.326, P=0.006 and Z=26.247, P=0.000, respectively). In addition, the initial virological response was higher in the T/T and T/C groups than the C/C group (chi(2)=5.674, P=0.017 and chi(2)=4.980, P=0.026, respectively). In 78 initially HBeAg-positive patients, however, the frequency of initial e-antigen disappearance or seroconversion among the T/T, T/C, and C/C genotype groups was 34.15%, 27.78% and 15.79%, respectively, which were not significantly different. CONCLUSION. The T29C genotype polymorphism of ESR1 is associated with the initial response to IFN-alpha in patients with chronic hepatitis B, and might be a significant marker for predicting the initial response to IFN-alpha, at least in this study population. (Hepatobiliary Pancreat Dis Int 2010; 9: 275-279) 展开更多
关键词 estrogen receptor POLYMORPHISM chronic hepatitis B initial response INTERFERON-alpha
下载PDF
Effects of Estrogen-related Receptor alpha (ERRα) on Proliferation and Metastasis of Human Lung Cancer A549 Cells 被引量:3
4
作者 黄建伟 管保章 +6 位作者 尹良红 刘璠娜 胡波 郑绮宜 李佛兰 钟影雪 陈宇 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2014年第6期875-881,共7页
Estrogen-related receptor alpha (ERRα) plays an important role in the development of hor- monezdependent cancers, but its roles in lung cancer remain elusive. The present study was aimed to investigate the effects ... Estrogen-related receptor alpha (ERRα) plays an important role in the development of hor- monezdependent cancers, but its roles in lung cancer remain elusive. The present study was aimed to investigate the effects of ERRα on the proliferation and metastasis of lung cancer A549 cells. The mRNA and protein levels of ERRor were detected in lung cancer A549 and MCF-7 cells and bronchial epithelial BEAS-2B cells by qRT-PCR and Western blotting, respectively. ERRor plasmid transfection and XCT-790 (an inverse agonist of ERRc0 were used to up-regulate or down-regulate ERRα expression in A549 cells, respectively. The viability of A549 cells was measured by cell counting kit-8 (CCK-8) and the motility of A549 cells by wound healing assay and Transwell migration/invasion assay. The epithelial markers E-cadherin (E-Cad) and zona occludin-1 (ZO-1), the mesenchymal markers fi- bronectin (FN) and vimentin (Vim) and the transcription factors (Snail, Zebl Twist and Slug) were fur- ther detected at mRNA and protein levels by qRT-PCR and Western blotting, respectively. The results showed that ERRor promoted the growth of lung cancer A549 cells in vitro. XCT-790 significantly in- hibited the migration and invasion of A549 cells. Over-expression of ERRα promoted the epithe- lial-to-mesenchymal transition (EMT) of A549 ceils, down-regulated the epithelial makers E-Cad and ZO-1, and up-regulated the mesenchymal makers FN and Vim. Silencing of Slug, but not other tran- scription factors, significantly abolished the ERRs-induced EMT of A549 cells. It was suggested that ERRor promoted the migration and invasion of A549 cells by inducing EMT, and Slug was involved in the process. Targeting ERRor might be an efficient approach for lung cancer treatment. 展开更多
关键词 estrogen-related receptor alpha XCT-790 MIGRATION INVASION A549 ceils
下载PDF
Expression of estrogen receptor alpha in preimplantation mice embryos 被引量:1
5
作者 Chen Yuezhou Li Jianhua +1 位作者 Chen Dongli Cui Sheng 《现代妇产科进展》 CSCD 北大核心 2007年第11期877-880,F0003,共5页
Objective:To study the expression of estrogen receptor alpha(ERα) in preimplantation mice embryos.Methods:Mice zygotes were collected from superovulated Kunming mice and cultured in vitro.Embryos at different develop... Objective:To study the expression of estrogen receptor alpha(ERα) in preimplantation mice embryos.Methods:Mice zygotes were collected from superovulated Kunming mice and cultured in vitro.Embryos at different developmental stages were collected at 0,24,36,48,72 and 96hours after cultivation.The expression of ERα in early mice embryos was detected by reverse transcription-PCR(RT-PCR) and immunocytochemistry.Results:The expression of ERα mRNA was detected in all of the examined embryonic stages.The relative amount of ERα mRNA showed no significant difference between 1-cell stage embryos and 4-cell stage embryos(P>0.05).However,the relative level of ERα mRNA significantly decreased(P<0.05) at 2-cell stage and was the lowest at this stage.Over 2-cell stage,the ERα mRNA relative level would increase and achieve the peak level at blastocyst stage.The location of immunocytochemistry showed that ERα immunopositive cells could be firstly detected at 8-cell stage,after which they are consistently detected until blastocyst stage.In addition,the intensity of ERα positive staining was higher at blastocyst stage compared with that at 8-cell stage and morula stage.Conclusion:ERα is expressed in preimplantation mice embryos in a temporal and spatial pattern and may be involved in regulating the development of early mice embryos,which probably plays crucial roles in early embryonic development. 展开更多
关键词 雌激素受体Α 胚胎植入 胚胎发育 基因表达
下载PDF
Expression of estrogen receptor alpha,nerve growth factor,interleukin-2,and androgen receptor in the cerebellum of ovariectomized rats following soybean isoflavone treatment
6
作者 Zhengli Chen Chunmei Zhu +2 位作者 Qihui Luo Kangcheng Pan Anchun Cheng 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第12期965-972,共8页
BACKGROUND: Studies have shown that estrogen receptor alpha (ERα), nerve growth factor (NGF), interleukin-2 (IL-2), and androgen receptor (AR) expression in the cerebellum decreases when estrogen levels decr... BACKGROUND: Studies have shown that estrogen receptor alpha (ERα), nerve growth factor (NGF), interleukin-2 (IL-2), and androgen receptor (AR) expression in the cerebellum decreases when estrogen levels decrease in vivo. Soybean isoflavone, a type of non-steroid estrogen with similar molecular structure and function to estradiol, exhibits estrogen-like characteristics. OBJECTIVE: To investigate the effects of various doses of soybean isoflavone on expression of ERa, NGF, IL-2, and AR in the cerebellum of ovariectomized rat, and to determine whether there is a dose-dependent effect.DESIGN, TIME AND SETTING: Controlled trial at the cellular and molecular level. The study was performed at the Experimental Animal Engineering Center, College of Veterinary Medicine, Sichuan Agricultural University from July 2006 to May 2008. MATERIALS: Soybean isoflavone, comprised of daidzin, genistein and isoflavone, was provided by Taiyuan Yuantai Biochemical Industry, China. The ERα, NGF, IL-2, and AR in situ hybridization kit, rabbit anti-rat ERa, NGF, IL-2, and AR monoclonal antibodies, and SABC kit were purchased from Wuhan Boster Biological Technology, China. METHODS: A total of 50 female, Sprague Dawley rats, aged 3 months, were randomly assigned to 5 groups, with 10 animals in each group. With the exception of the sham-operation group (abdominal cavity opening alone), all rats underwent bilateral ovariectomy. At 14 days after surgery, rats in the high-, middle-, and low-dose soybean isoflavone groups were subcutaneously injected with 1.5, 1.0, and 0.5 mg/kg soybean isoflavone, respectively, every 2 days for 6 consecutive weeks. Rats in the sham-operation and ovariectomized groups were subcutaneously injected with absolute alcohol (0.5 mL/kg). MAIN OUTCOME MEASURES: Expression levels and distribution of ERα, NGF, IL-2, and AR in the cerebellum were detected by immunohistochemistry and in situ hybridization. RESULTS: Compared with the sham-operation group, immunoreactive products and hybridization signals of ERa, NGF, IL-2, and AR were significantly decreased in the cerebellar cortex and nuclei of ovariectomized rats (P 〈 0.05 or P 〈 0.01), but increased following soybean isoflavone treatment. In particular, levels of the high-dose soybean isoflavone group were almost restored to levels of the sham-operation group (P 〉 0.05). The immunoreactive products were primarily located in the cytoplasm and neurites, and rarely in the cell membrane and nuclei. However, the hybridization signals were predominantly located in the nuclei, but rarely in the cytoplasm, cell membrane, or neurites. CONCLUSION: Soybean isoflavone upregulated ERα, NGF, IL-2, and AR protein and gene expression in a dose-dependent manner, and played an important role in sustaining and protecting structure and function of cerebellar neurons. Moreover, the similarity of expression patterns of these molecules indicated that they were mutually interactive during the regulation of soybean isoflavone to the cerebellum. 展开更多
关键词 soybean isoflavone estrogen receptor alpha nerve growth factor INTERLEUKIN-2 androgen receptor CEREBELLUM
下载PDF
Estrogen Receptor Alpha 36 Gene Knockdown Promote the Expression of NF-κB in PC12 Cells
7
作者 Ping Zou Chao Qu +4 位作者 Yihui Xu Hongyan Li Dannv Han Dan Shi Wei Zou 《Open Journal of Endocrine and Metabolic Diseases》 2013年第4期20-24,共5页
The nuclear transcription factors κB (NF-κB) is widely existing in various kinds of cell types in the nervous system and plays an important role in neuron apoptosis and neurodegenerative diseases. Estrogen receptor ... The nuclear transcription factors κB (NF-κB) is widely existing in various kinds of cell types in the nervous system and plays an important role in neuron apoptosis and neurodegenerative diseases. Estrogen receptor alpha 36 (ER-α36), is a novel variant of ERα (as known ER-α66) which can transduce both estrogenand antiestrogen-dependent activation of MAPK signal pathway and stimulate cell growth. Here, we aimed to detect the effect of ER-α36 gene silencing on the expression of NF-κB in normal cultured PC12 cells and to provide an experimental foundation for understanding the function of ER-α36 innerve cells. PC12 cells with ER-α36 expression knocked down by the shRNA method. Then Western blot and immunocytochemical staining were performed to detect the expression and translocation of NF-κB after transfection. The results showed that NF-κB expression was significantly higher comparing with the control group after transfection (P 0.01). Also, NF-κB subunit entered nuclear after transfection;Immunofluorescence staining and immunocytochemical staining of PC12 cells demonstrated that ER-α36 was expressed mainly on the plasma membrane and on the cell nucleus membrane. These data indicate that ER-α36 gene silencing can increase the expression of NF-κB and promote its nuclear translocation in PC12 cells. 展开更多
关键词 NF-ΚB estrogen receptor alpha 36 PC12 Cells
下载PDF
乳腺癌组织中COL11A1表达与ER、PR、HER-2和Ki-67的相关性分析 被引量:1
8
作者 季盼 杨允博 +3 位作者 白茹梦 贺骁 吕君文 缪琛 《临床肿瘤学杂志》 CAS 2023年第12期1004-1007,共4页
目的探讨乳腺癌组织中Ⅺ型胶原α1(COL11A1)表达与雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体-2(HER-2)和Ki-67的关系。方法采用免疫组化EnVision两步法检测18例乳腺纤维腺瘤组织和120例乳腺癌组织(36例原位癌组织、84例浸润... 目的探讨乳腺癌组织中Ⅺ型胶原α1(COL11A1)表达与雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体-2(HER-2)和Ki-67的关系。方法采用免疫组化EnVision两步法检测18例乳腺纤维腺瘤组织和120例乳腺癌组织(36例原位癌组织、84例浸润性癌组织)中COL11A1的表达,同时对乳腺癌组织进行ER、PR、HER-2和Ki-67免疫组化检测,对HER-2(2+)进行荧光原位杂交检测;分析COL11A1表达与乳腺癌临床病理特征和多种免疫标记(ER、PR、HER-2和Ki-67)的关系。结果免疫组化结果显示COL11A1主要表达于乳腺癌细胞中。在纤维腺瘤组织中COL11A1表达呈弱阳性。COL11A1在原位癌中表达高于浸润性乳腺癌(P<0.05)。COL11A1表达与乳腺癌患者的年龄、部位、肿块大小和淋巴结转移无关(P>0.05),而中、高分化组织的COL11A1表达水平高于低分化组织,差异有统计学意义(P<0.05)。进一步分析COL11A1与乳腺癌其他免疫标记间的相关性发现,在Ki-67高表达组织中COL11A1低表达的比例更高,差异有统计学意义(P<0.05),而其他3种标记与COL11A1的表达无关(P>0.05)。结论COL11A1在浸润性乳腺癌中表达较原位癌低,在低分化乳腺癌中表达水平较中高分化更低,且与Ki-67表达有关,提示COL11Al表达在乳腺癌发生发展过程中是动态变化的,为乳腺癌的诊断治疗提供潜在标记物。 展开更多
关键词 乳腺癌 Ⅺ型胶原α1 雌激素受体 孕激素受体 人表皮生长因子受体-2 KI-67
下载PDF
Expression of estrogen receptor (ER) -α and -βtranscripts in the neonatal and adult rat cerebral cortex, cerebellum, and olfactory bulb 被引量:1
9
作者 GuoXZ SuJD 《Cell Research》 SCIE CAS CSCD 2001年第4期321-324,共4页
In the present study expression of estrogen receptor subtype -α(ERα) and -β (ERβ) in the cerebral cortex, cerebellum, and olfactory bulb was investigated and compared between neonatal (1~3-days-old) and adult (25... In the present study expression of estrogen receptor subtype -α(ERα) and -β (ERβ) in the cerebral cortex, cerebellum, and olfactory bulb was investigated and compared between neonatal (1~3-days-old) and adult (250~350g) rats, using reverse transcription-polymerase chain reaction (RT- PCR). No ERα transcripts were detectable in the adult cerebellum and olfactory bulb, whereas very weak expression of ERα was present in the adult cerebral cortex. No significant difference in ERβ transcripts was detectable between the neonatal and adult rats. While transcripts for both ER subtypes were co-expressed in these brain areas of neonatal rats, although ERα expression was significantly weaker than ERβ. Even in the cerebral cortex known to contain both ER subtypes in adult rats, ERα transcripts in neonatal rats were much higher than in adult. These observations provide evidence for the existence of different expression patterns of ERcα/ERβ transcripts in these three brain areas between the neonatal and adult rats, suggesting that each ER subtype may play a distinct role in the regulation of differentiation, development, and functions of the brain by estrogen. 展开更多
关键词 初生 成年 大脑皮层 小脑 雌激素受体 嗅球 RT-PCR
下载PDF
“逆针灸”干预对去卵巢大鼠下丘脑不同核团ER-α和ER-αmRNA表达水平的影响 被引量:10
10
作者 李晓泓 郑玲 +7 位作者 解秸萍 张露芬 翟景慧 周军 田阳春 周登芳 何玉伟 曲黎敏 《中国针灸》 CAS CSCD 北大核心 2008年第12期918-922,共5页
目的:探索"逆针灸"对去卵巢大鼠下丘脑功能的调节机制。方法:将3.5月龄SD雌性大鼠30只,随机分为正常组、假手术组、去卵巢模型组、逆针组、逆灸组。逆灸组与逆针组分别预先艾灸、针刺1个月后,与去卵巢模型组、假手术组同时造... 目的:探索"逆针灸"对去卵巢大鼠下丘脑功能的调节机制。方法:将3.5月龄SD雌性大鼠30只,随机分为正常组、假手术组、去卵巢模型组、逆针组、逆灸组。逆灸组与逆针组分别预先艾灸、针刺1个月后,与去卵巢模型组、假手术组同时造模。采用免疫组化和原位杂交方法,观察各组大鼠下丘脑室旁核、视上核、弓状核雌激素受体-α(ER-α)和基因表达水平的变化。结果:大鼠去卵巢后下丘脑室旁核ER-α及ER-αmRNA,视上核ER-αmRNA表达均明显升高(P<0.01),视上核、弓状核ER-α表达明显降低(P<0.01);与去卵巢模型组比较预先进行"逆针灸"处理后,大鼠下丘脑室旁核ER-αmRNA表达明显降低(P<0.05),ER-α无明显变化(P>0.05),视上核、弓状核ER-α表达明显升高(P<0.01,P<0.05),视上核ER-αmRNA无明显变化(P>0.05)。结论:"逆针灸""关元"穴能够影响去卵巢更年期大鼠下丘脑不同核团ER-α和ER-αmRNA表达水平的变化,可能是其调节下丘脑功能活动的途径之一。 展开更多
关键词 逆针灸 大鼠 Sprague-Dawley 卵巢切除术 下丘脑 下丘脑室旁核 雌激素受体alpha
下载PDF
ER-α36过表达促进人乳腺癌MCF-7细胞侵袭转移能力 被引量:10
11
作者 刘旺根 张钦宪 +4 位作者 王云龙 孙新城 王国强 李恒思 李玉林 《基础医学与临床》 CSCD 北大核心 2013年第6期713-717,共5页
目的探讨雌激素受体新亚型ER-α36过表达对人雌激素受体阳性乳腺癌细胞侵袭转移潜力的影响及其机制。方法以野生型乳腺癌细胞系MCF-7/W、转染pcDNA3.1空载体的细胞系MCF-7/pcDNA3.1和转染重组载体pcDNA3.1/ER-α36的细胞系MCF-7/ER-α3... 目的探讨雌激素受体新亚型ER-α36过表达对人雌激素受体阳性乳腺癌细胞侵袭转移潜力的影响及其机制。方法以野生型乳腺癌细胞系MCF-7/W、转染pcDNA3.1空载体的细胞系MCF-7/pcDNA3.1和转染重组载体pcDNA3.1/ER-α36的细胞系MCF-7/ER-α36为研究对象,分别用细胞黏附实验观测肿瘤细胞与细胞外基质的黏附能力、Transwell侵袭小室实验检测细胞侵袭转移能力,用Western blot法检测NF-κB P65、MMP-2、MMP-9和TIMP-1蛋白表达。结果与MCF-7/W组细胞相比,MCF-7/ER-α36细胞的2 h细胞黏附率和24 h穿膜细胞数显著增加(P<0.05)。NF-κB P65、MMP-2、MMP-9和TIMP-1蛋白的相对表达量及MMP-2/TIMP-1、MMP-9/TIMP-1显著增高(P<0.05)。结论 ER-α36过表达能促进ER-α66阳性乳腺癌细胞的体外黏附能力和侵袭转移潜力,其机制可能与通过NF-κB途径提高MMP-2、MMP-9的表达水平及打破二者与TIMP-1之间的平衡有关。 展开更多
关键词 乳腺癌 雌激素受体-α36 MCF-7细胞系 侵袭转移 核因子-ΚB
下载PDF
雌激素受体α在绝经后骨质疏松中的研究进展及作用机制
12
作者 瞿霖 赵梦幻 +2 位作者 王冬玉 宋蕾 周昆 《中国骨质疏松杂志》 CAS CSCD 北大核心 2024年第7期1021-1027,共7页
绝经后骨质疏松(postmenopausal osteoporosis, PMOP)是亟需解决的公共健康问题。患者雌激素减少,雌激素受体(estrogen receptor α,ERα)表达水平下降,成骨细胞功能下降,破骨细胞活性增强,骨代谢偶联失衡。ERα在PMOP的发生发展中具有... 绝经后骨质疏松(postmenopausal osteoporosis, PMOP)是亟需解决的公共健康问题。患者雌激素减少,雌激素受体(estrogen receptor α,ERα)表达水平下降,成骨细胞功能下降,破骨细胞活性增强,骨代谢偶联失衡。ERα在PMOP的发生发展中具有重要作用,笔者从PubMed、Web of Science和中国知网检索近10年(2013-2023年)骨质疏松研究领域的文献,总结归纳ERα在骨髓间充质干细胞、成骨细胞祖细胞、成骨细胞前体细胞、成熟成骨细胞、破骨细胞和骨细胞中的作用,并以能显著改善PMOP的黄酮类成分淫羊藿苷为例阐述基于ERα的抗PMOP相关机制。 展开更多
关键词 绝经后骨质疏松 雌激素受体Α 成骨细胞 破骨细胞
下载PDF
多溴二苯醚类化合物干扰人雌激素受体alpha活性机理的理论研究 被引量:1
13
作者 杨伟华 于红霞 《环境化学》 CAS CSCD 北大核心 2013年第7期1168-1179,共12页
基于分子对接方法探讨了多溴二苯醚(PBDEs)类化合物与人雌激素受体α亚型间的分子作用机理.对多溴二苯醚类化合物是否具有拟雌激素功能的研究得出:可通过对接打分值和化合物结构特征来推测PBDEs母体化合物是否具有拟雌激素活性;对HO-PBD... 基于分子对接方法探讨了多溴二苯醚(PBDEs)类化合物与人雌激素受体α亚型间的分子作用机理.对多溴二苯醚类化合物是否具有拟雌激素功能的研究得出:可通过对接打分值和化合物结构特征来推测PBDEs母体化合物是否具有拟雌激素活性;对HO-PBDEs,与氨基酸残基GLU53和/或ARG394形成氢键可能是影响其拟雌激素活性的重要因素;对MeO-PBDEs,疏水MeO-位于结合腔的疏水中部有利于拟雌激素活性.从结构及构象分析得出,邻位疏水基(Br-、MeO-)有利于PBDEs类化合物的拟雌激素活性.同时对多溴二苯醚类化合物是否具有抗雌激素功能的结合特征研究发现,表现出抗雌激素活性的部分PBDEs类化合物伸进通常被雌激素受体拮抗剂雷洛昔芬和4-羟基它莫西芬的烷基胺侧链占据的通道,而大多数未表现出抗雌激素活性的PBDEs类化合物的结合模式类似雌激素受体激动剂17β-雌二醇,位于结合腔,没有伸进通道.本研究从化合物结构及化合物在受体内结合的构象特征上解释化合物活性不同的原因,以期能够利用构象分析得到的结果进行筛选. 展开更多
关键词 多溴二苯醚类化合物 人雌激素受体α亚型 分子作用机理 分子对接
下载PDF
Ang-2、Tie-2与ER-α在子宫内膜异位症中的表达及意义 被引量:5
14
作者 宋娟 马洪达 +1 位作者 尹利荣 孙俊杰 《天津医药》 CAS 北大核心 2009年第9期734-736,共3页
目的:探讨血管生成素2(Ang-2)及其酪氨酸蛋白激酶受体2(Tie-2)和雌激素受体α(ER-α)在子宫内膜异位症(内异症)发病中的表达。方法:选择30例内异症患者的在位内膜作为内异症组,30例卵巢其他良性肿瘤患者的子宫内膜作为对照组,增殖期和... 目的:探讨血管生成素2(Ang-2)及其酪氨酸蛋白激酶受体2(Tie-2)和雌激素受体α(ER-α)在子宫内膜异位症(内异症)发病中的表达。方法:选择30例内异症患者的在位内膜作为内异症组,30例卵巢其他良性肿瘤患者的子宫内膜作为对照组,增殖期和分泌期各15例,应用免疫组织化学SP法检测Ang-2、Tie-2和ER-α在其中的表达。结果:Ang-2和Tie-2主要在子宫内膜的腺上皮表达,血管内皮和间质也有少许表达,但较腺上皮表达少,定位于细胞浆。ER-α在子宫内膜腺上皮和间质均有表达,定位于细胞核。内异症组的增殖期和分泌期内膜中Ang-2表达,分泌期时Tie-2的表达,增殖期ER-α的表达均显著高于对照组(P<0.05或P<0.01)。2组增殖期时Tie-2的表达,分泌期时ER-α的表达差别无统计学意义(P>0.05)。Ang-2及Tie-2在2组中的表达均是分泌期高于增殖期,ER-α则是增殖期高于分泌期(P<0.05)。结论:内异症在位内膜分泌期的Ang-2和Tie-2及增殖期ER-α高表达可能与内异症的发病有密切关系。 展开更多
关键词 子宫内膜异位症 免疫组织化学 血管生成素2 受体 TIE-2 雌激素受体Α
下载PDF
POP患者子宫骶韧带组织中胶原纤维、弹力纤维形态学变化及HOXA11、ER-α和ER-β的表达及其意义 被引量:4
15
作者 郭洁 黄向华 +6 位作者 张琳 杜彦芳 李晓冬 李雅钗 赵金钗 尹桂然 王振海 《实用妇产科杂志》 CAS CSCD 北大核心 2012年第1期32-35,共4页
目的:探讨子宫骶韧带局部组织中同源盒基因A11(HOXA11)、雌激素受体α(ER-α)、雌激素受体β(ER-β)的表达及胶原纤维、弹力纤维形态的改变与盆腔器官脱垂(POP)发生的关系。方法:采用免疫组织化学PV法检测24例(POP及非POP各12例,分别为... 目的:探讨子宫骶韧带局部组织中同源盒基因A11(HOXA11)、雌激素受体α(ER-α)、雌激素受体β(ER-β)的表达及胶原纤维、弹力纤维形态的改变与盆腔器官脱垂(POP)发生的关系。方法:采用免疫组织化学PV法检测24例(POP及非POP各12例,分别为研究组和对照组)子宫骶韧带组织中HOXA11、ER-α、ER-β的表达,应用间苯二酚品红法和丽春红酸性品红法分别对弹性纤维和胶原纤维进行染色。结果:①HE染色显示研究组子宫骶韧带组织有胞浆水肿、空泡变性及淀粉样变等不同程度的变性。②与对照组相比,研究组胶原纤维染色较浅,弹力纤维弯曲度和密度减低,纤维碎裂、崩解或聚集成团块状,排列相对不规则。③研究组HOXA11、ER-α和ER-β表达均减弱,与对照组相比,差异有统计学意义(P<0.05)。结论:POP患者子宫骶韧带组织发生变性,其弹力纤维的形态遭到破坏,胶原纤维的含量减少。HOXA11、ER-α和ER-β在POP患者子宫骶韧带组织中的表达均降低,提示均参与POP的发生。 展开更多
关键词 盆腔器官脱垂 子宫骶韧带 同源盒基因A11 雌激素受体α和β
下载PDF
ER-α-ERK5信号通路介导流体剪切力促进MC3T3-E1细胞增殖 被引量:1
16
作者 孟会强 姜金 +3 位作者 郭来威 许田恩 丁宁 夏亚一 《中国医学物理学杂志》 CSCD 2017年第3期291-296,共6页
目的:研究雌激素受体α(ER-α)在流体剪切力促进细胞外信号调节激酶5(ERK5)活化以及ER-α-ERK5信号通路在成骨细胞增殖中的具体分子机制。方法:给予成骨MC3T3-E1细胞孵育特异性ER-α抑制剂MPP(methyl-piperidinopyrazole,1μmol/L),孵... 目的:研究雌激素受体α(ER-α)在流体剪切力促进细胞外信号调节激酶5(ERK5)活化以及ER-α-ERK5信号通路在成骨细胞增殖中的具体分子机制。方法:给予成骨MC3T3-E1细胞孵育特异性ER-α抑制剂MPP(methyl-piperidinopyrazole,1μmol/L),孵育高选择性ERK5活性抑制剂XMD8-92(5μmol/L),和/或加载12 dyn/cm^2流体剪切力处理。采用MTT实验检测成骨细胞的增殖活性,采用蛋白免疫印记实验检测ER-α、P-ERK5、ERK5、Cyclin D1(细胞周期蛋白)和CDK4(细胞周期蛋白依赖性激酶)蛋白的表达水平。结果:生理强度(12 dyn/cm^2)的流体剪切力作用于成骨MC3T3-E1细胞60 min后能显著促进成骨细胞增殖,促进Cyclin D1和CDK4的表达;同时ER-α和P-ERK5的表达显著增加。成骨细胞孵育MPP抑制ER-α后,P-ERK5的表达显著下降,Cyclin D1和CDK4表达也显著降低。孵育XMD8-92抑制ERK5活性后,流体剪切力促进成骨细胞中Cyclin D1和CDK4表达水平显著下降。结论:流体剪切力通过ER-α-ERK5信号通路上调Cyclin D1和CDK4的表达水平,最终导致成骨MC3T3-E1细胞增殖。 展开更多
关键词 流体剪切力 MC3T3-E1细胞 细胞增殖 细胞外信号调节激酶5 雌激素受体α 细胞周期蛋白 细胞周期蛋白依赖性激酶
下载PDF
人源性雌激素受体alpha高表达慢病毒载体的构建与鉴定
17
作者 刘根霞 王子露 +3 位作者 景双林 闫明 张光东 于金华 《口腔医学》 CAS 2015年第5期326-328,共3页
目的构建人源性雌激素受体alpha(ERα)高表达慢病毒载体,以用于后续雌激素受体对牙源性干细胞分化能力的研究。方法以p EGFP-ERα为模板,RT-PCR方法体外扩增ERα基因,经测序后重组入慢病毒载体PMSCV-GFP,将正确构建的PMSCV-ERα质粒导入... 目的构建人源性雌激素受体alpha(ERα)高表达慢病毒载体,以用于后续雌激素受体对牙源性干细胞分化能力的研究。方法以p EGFP-ERα为模板,RT-PCR方法体外扩增ERα基因,经测序后重组入慢病毒载体PMSCV-GFP,将正确构建的PMSCV-ERα质粒导入293T细胞进行PMSCV-ERα慢病毒制备,Western Blot检测ERα的表达水平。结果体外成功扩增ERα并重组入PMSCV-GFP慢病毒载体,Western Blot结果显示PMSCV-ERα组的ERα水平较对照组(PMSCV-GFP组)表达明显增高。结论成功构建人源性雌激素受体alpha高表达慢病毒载体。 展开更多
关键词 雌激素受体alpha 慢病毒载体 293T细胞
下载PDF
雌激素相关受体alpha特性抑制剂XCT-790对细胞糖代谢的影响
18
作者 杨冰 王海彬 +5 位作者 梁笃 王军舰 方芳 高明慧 刘文明 周曦 《当代医学》 2010年第18期24-25,共2页
目的探讨雌激素相关受体α(ERRα)特异性抑制剂XCT-790对细胞糖代谢的影响。方法采用同位素示踪技术检测XCT-790对细胞糖酵解和糖吸收的影响,实时定量PCR检测XCT-790对糖代谢相关基因表达的影响。结果 ERRα特异性抑制剂XCT-790可以显... 目的探讨雌激素相关受体α(ERRα)特异性抑制剂XCT-790对细胞糖代谢的影响。方法采用同位素示踪技术检测XCT-790对细胞糖酵解和糖吸收的影响,实时定量PCR检测XCT-790对糖代谢相关基因表达的影响。结果 ERRα特异性抑制剂XCT-790可以显著地增加细胞的糖酵解和糖吸收,并降低ERRa靶基因SDH和Nduf表达,增加糖代谢相关基因Tigar的表达。结论 ERRα特异性抑制剂XCT-790可以显著地增加癌细胞糖酵解和糖代谢。 展开更多
关键词 雌激素相关受体alpha 糖酵解 糖吸收 XCT-790
下载PDF
Effects of delayed estrogen treatment and 20-HETE synthesis inhibition on postischemic pial artery response to acetylcholine in rats
19
作者 Chikao Miyazaki Emil N. Zeynalov +1 位作者 Raymond C. Koehler Marguerite T. Littleton-Kearney 《Open Journal of Molecular and Integrative Physiology》 2014年第1期1-10,共10页
Relatively little is known about the effects of estrogen on postischemic cerebral vasomotor dynamics after ischemic injury. Emerging hypotheses suggest that the timing after menopause at which hormone replacement is i... Relatively little is known about the effects of estrogen on postischemic cerebral vasomotor dynamics after ischemic injury. Emerging hypotheses suggest that the timing after menopause at which hormone replacement is initiated might be important and might modulate the potential benefits of estrogen on brain rescue once a cerebral ischemic event occurs. Therefore, we sought to determine if protracted hypoestrogenicity modifies estrogen’s protective effects on postischemic pial artery dilatory dysfunction and if the arachidonic acid metabolite 20-hydroxyeicosatetraeonic (20-HETE) contributes to the dysfunction. Pial artery dilation to acetylcholine was examined before and 1 hour after 15 minutes forebrain ischemia. The rat study groups included: sexually mature males (M), naive (N), OVX (OV), estrogen-treated OVX females (E1;estrogen started 1 week post ovariectomy) and delayed estrogen-treated (E10;started 10 weeks post ovariectomy) females. Postischemic responses were assessed before and after superfusion of the 20-HETE synthesis inhibitor N-hydroxy-N’-(4-butyl-2-methylphenyl)-formamidine (HET0016). Postischemic acetylcholine dilation was depressed in M, OV and E10 compared to N and E1 rats. Compared to E1, delayed estrogen replacement worsened acetylcholine-induced dilation. Postischemic microvascular estrogen receptor alpha (ERα) density was similar in the OV, E1 and E10 rats. Postischemic application of HET0016 failed to improve acetylcholine dilation. Continuous infusion of HET0016 during and after ischemia did not reverse postischemic pial vasodilatory dysfunction. Timing of estrogen replacement may be critical for vascular health after cerebral ischemic injury. Postischemic loss of acetylcholine reactivity does not appear to involve mechanisms related to 20-HETE synthesis or microvascular ERα expression. 展开更多
关键词 Hypoestrogenicity estrogen Replacement CEREBRAL ISCHEMIA/REPERFUSION CEREBRAL MICROVESSELS estrogen receptor alpha 20-HETE HET0016
下载PDF
丙泊酚减少乳腺癌患者术后复发率的网络药理学和分子对接分析 被引量:2
20
作者 焦梓茵 杨峰 林成新 《临床麻醉学杂志》 CAS CSCD 北大核心 2023年第1期59-65,共7页
目的乳腺癌患者术后血液里的肿瘤细胞数是复发率升高和生存率降低的独立影响因素。丙泊酚虽然已经被证实能减少乳腺癌患者术后血液循环里的肿瘤数,但是丙泊酚是否能直接与乳腺癌细胞相互作用、通过什么受体与乳腺癌细胞相互作用仍然处... 目的乳腺癌患者术后血液里的肿瘤细胞数是复发率升高和生存率降低的独立影响因素。丙泊酚虽然已经被证实能减少乳腺癌患者术后血液循环里的肿瘤数,但是丙泊酚是否能直接与乳腺癌细胞相互作用、通过什么受体与乳腺癌细胞相互作用仍然处于未知状态,因此本研究通过网络药理学技术、癌症基因组图谱(TCGA)数据挖掘、分子对接技术试图探索出丙泊酚与乳腺癌细胞直接作用的靶点及相关的通路。方法在PubChem数据库中检索出丙泊酚的3D结构和Canonical smiles序列并在Swiss Target prediction、Chembl、Drugbank三个数据库中整合出丙泊酚的作用位点,在Uniprot数据库中转换成基因名称。在DisGeNet、Gene cards数据库中检索出与乳腺癌相关的基因。将上述两组基因数据集取交集得到19个共有基因。将得到的基因进行京都基因与基因组百科全书(KEGG)、基因本体论(GO)富集分析。筛选出与乳腺癌相关的KEGG通路和基因,并在TCGA乳腺癌的基因表达数据集中对筛选出的基因进行验证。最后使用分子对接技术将丙泊酚分子和雌激素受体α(ESRα)进行对接验证。结果丙泊酚作用靶点数据集与乳腺癌相关基因数据集有19个共有基因,KEGG分析中雌激素信号通路是与乳腺癌最相关的通路,富集在这条通路上的基因有γ氨基丁酸B型受体基因(GABBR1,GABBR2)、雌激素受体基因(ESR1)。在TCGA乳腺癌基因表达数据集中分析上述3个基因在肿瘤组织和非肿瘤组织中的差异性表达情况,发现上述3个基因在肿瘤组织和非肿瘤组织中存在明显的差异性表达,分子对接结果显示丙泊酚与ESRα结合良好。结论丙泊酚可能通过与乳腺癌细胞膜上的GABA B受体和雌激素受体结合,影响乳腺癌细胞的“膜启动类固醇信号传导”,从而减少乳腺癌细胞术中的微转移,减少乳腺癌患者术后血液循环内的肿瘤细胞数量,最终减少乳腺癌患者术后复发率。 展开更多
关键词 丙泊酚 乳腺癌 网络药理学 雌激素受体Α
下载PDF
上一页 1 2 12 下一页 到第
使用帮助 返回顶部